在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

KLK2 Antibody, FITC conjugated

  • 中文名稱:
    KLK2兔多克隆抗體, FITC偶聯(lián)
  • 貨號:
    CSB-PA012453LC01HU
  • 規(guī)格:
    ¥880
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品名稱:
    Rabbit anti-Homo sapiens (Human) KLK2 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 別名:
    Glandular kallikrein 2 antibody; Glandular kallikrein-1 antibody; hGK 1 antibody; hGK-1 antibody; hK2 antibody; Kallikrein 2 prostatic antibody; Kallikrein related peptidase 2 antibody; kallikrein, glandular antibody; Kallikrein, prostatic antibody; Kallikrein-2 antibody; KLK 2 antibody; Klk-2 antibody; Klk2 antibody; KLK2_HUMAN antibody; KLK2A 2 antibody; KLK2A2 antibody; MGC12201 antibody; Tissue kallikrein 2 antibody; Tissue kallikrein-2 antibody; Ton antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human
  • 免疫原:
    Recombinant Human Kallikrein-2 protein (25-261AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    FITC
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
  • 產(chǎn)品提供形式:
    Liquid
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點(diǎn)詳情

  • 功能:
    Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin.
  • 基因功能參考文獻(xiàn):
    1. glycosylation changes the enzymatic activity of KLK2 in a drastically substrate-dependent manner. PMID: 26582203
    2. The results indicated that W-hK2 had a defect in cellular trafficking due to its misfolding and that it activated the unfolded protein response, suggesting a mechanism to explain the association of the T allele with higher prostate cancer risk. PMID: 25847286
    3. miR-378 was predicted to target both KLK2 and KLK4 and downregulated levels detected in prostate cancer patients. PMID: 25153390
    4. The differential regulation of alternative transcripts (using KLK2, KLK3 and KLK4 as models) by androgens and anti-androgens as an indicator of prostate cancers, was investigated. PMID: 25153393
    5. Structure-function analyses of KLK2 establish the 99-loop as master regulator of its activity. PMID: 25326387
    6. Predictions based on levels of four kallikrein markers, including KLK2, in blood distinguish between pathologically insignificant and aggressive disease after radical prostatectomy with good accuracy. PMID: 23683475
    7. Alteration of cellular junctions in benign prostatic hyperplasia could contribute to the presence of luminal epithelial secreted proteins prostate specific antigen (PSA)2 and and KLK2 in the stromal compartment. PMID: 24711254
    8. we present the first evidence that KLK2 can also function as an androgen receptor modulator that may modulate cell growth after the development of castration-resistant prostate cancer PMID: 24122203
    9. Associations observed in young, healthy men between the seminal plasma and serum concentrations of hK2 and PSA and several genetic variants in KLK2 and KLK3 could be useful to refine models of PSA cutoff values in prostate cancer testing. PMID: 24270797
    10. Genetic variants at ATF7IP and KLK2 contribute to the variance of %fPSA. PMID: 23359319
    11. Two SNPs, in beta-microseminoprotein at and in kallikrein-related peptidase 2 at, are associated with PCA3 score at genome-wide significance level PMID: 23555189
    12. TK promotes vessel growth by increasing the number of EPCs and enhancing their functional properties through the kinin B(2) receptor-Akt signaling pathway. PMID: 22435954
    13. An exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer was found to be less likely associated with low Gleason score morphology. PMID: 21178268
    14. we identifiedand genotyped novel single-nucleotide polymorphisms in cancer cases and controls which verified prior associations in KLK2 and in MSMB (but not in KLK3) with prostate cancer PMID: 20424135
    15. Data show six non-synonymous amino acid or frame shift changes in the KLK3 gene and three changes in each of the neighboring genes, KLK15 and KLK2. PMID: 19823874
    16. The identification of unusual mRNA splice variants of the KLK2 and KLK3 genes that result from inclusion of intronic sequences adjacent to the first exon. PMID: 11834722
    17. Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. PMID: 12124798
    18. kallikrein expression in nipple aspirate fluid- ethnic variation PMID: 12209605
    19. Measurements of free prostate specific antigen and hK2 improve on our ability to counsel patients prior to treatment as to their risk of biochemical recurrence PMID: 16152616
    20. An additional serum marker for the detection of prostatic cancer. PMID: 16388506
    21. a role for the KLK2 gene in prostate cancer susceptibility PMID: 17085659
    22. results imply that prostate cancer risk is associated with androgen receptor(AR)-CAG repeat and kallikrein-2 polymorphisms in Indian population but no unambiguous association was observed with PSA and AR-GGN repeat polymorphism PMID: 17257635
    23. role of kallikrein gene 2 and 3 variant SNPs in the etiology of prostate cancer among men of European ancestry PMID: 17593395
    24. %fPSA and hK2 add important predictive value in older men and much closer to diagnosis PMID: 17657743
    25. The two novel ETV4 fusion partners possess as predominant common characteristics androgen-induction and prostate-specific expression. PMID: 18451133
    26. Recombinant hK2 activates ERK1/2 signaling of prostate cancer cell lines, which express both PAR1 and PAR2. PMID: 18567807
    27. adding free PSA and human kallikrein 2 to standard pretreatment risk-assessment models to predict biochemical recurrence after radical prostatectomy for prostate cancer enhanced the AUC PMID: 19003994
    28. PSA and kallikrein 2 transcripts in the peripheral blood of prostate cancer patients during barchytherapy could serve as a predictor of biochemiacl outcome. PMID: 19434652
    29. Observational study of gene-disease association, gene-gene interaction, and genetic testing. (HuGE Navigator) PMID: 19223501

    顯示更多

    收起更多

  • 蛋白家族:
    Peptidase S1 family, Kallikrein subfamily
  • 數(shù)據(jù)庫鏈接:

    HGNC: 6363

    OMIM: 147960

    KEGG: hsa:3817

    STRING: 9606.ENSP00000313581

    UniGene: Hs.515560



主站蜘蛛池模板: 精品国偷自产在线| 天堂最新版在线www官网中文地址| 婷婷综合久久中文字幕| 18禁男女爽爽爽午夜网站免费| 免费国产a国产片高清网站| 强伦姧人妻免费无码电影| 男女啪啪激烈高潮喷出gif免费| 在线观看国产一区二区三区| www国产亚洲精品久久麻豆| 国色天香社区视频手机免费| 国产成人精品a视频免费福利| 欧洲精品久久久av无码电影| 久久亚洲私人国产精品va| 99久久无色码中文字幕人妻蜜柚| 国产精品成人99久久久久| 轻点好疼好大好爽视频| 丰满少妇被猛烈进入| 在线中文字幕乱码英文字幕正常| 一本一道久久综合久久| 99久久精品国产波多野结衣| 无码少妇一区二区| av无码国产精品麻豆| 国精产品48x国精产品| 一二三四在线视频社区3| 无码人妻精品一区二区三| 天天爱天天做久久狠狠做| 亚洲6080yy久久无码产自国产| 免费人成在线观看视频播放| 无遮挡激情视频国产在线观看| 久九九久视频精品免费| 人妻在线日韩免费视频| 波多野42部无码喷潮在线| 97久久超碰精品视觉盛宴| 华人少妇被黑人粗大的猛烈进| 黑人大荫蒂高潮视频| 欧美亚洲人成网站在线观看| 成人三级无码视频在线观看| 亚洲欧美国产精品久久久久久久 | 亚洲欧美日韩中字视频三区| 亚洲一区二区三区中文字幕在线| 人妻无码视频一区二区三区|